
Pure Global: Brazil's AI Rulebook - Cracking the New Medical AI Framework
LATAM MedTech Insights · Ran Chen
March 30, 20261m 59s
Audio is streamed directly from the publisher (episodes.captivate.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, we dive into the landmark new resolution from Brazil’s Federal Council of Medicine (CFM) that creates a specific regulatory framework for Artificial Intelligence in medicine. This is a pivotal moment for digital health in Latin America, establishing new rules for physician oversight, data privacy, and the responsibilities of technology providers.
We explore the immediate impact on MedTech and IVD manufacturers aiming to launch AI-powered solutions in the Brazilian market. This isn't just a guideline for doctors. it's a new set of requirements for the tools they use. We break down what this means for product design, technical documentation, and your overall market access strategy in Brazil.
**Case Study:**
A European MedTech firm has a powerful AI diagnostic software for radiology. They considered Brazil a prime market but were operating in a grey area. Now, the CFM resolution provides a path, but one with new obstacles. How must they adapt their AI's user interface to meet the "human oversight" mandate, and how can they prove their data processing is fully compliant with Brazil's stringent LGPD privacy law without a costly redesign?
**Key Takeaways:**
- How does the CFM's focus on physician liability change your product's risk management file?
- Is your AI's algorithm explainable enough to meet the new transparency requirements?
- What specific steps must you take to ensure your data practices are compliant with both the CFM resolution and Brazil's LGPD?
- How will you need to modify your training and support materials for Brazilian medical professionals?
- Does this new resolution require a separate clinical validation study for the Brazilian population?
- How could this physician-centric framework in Brazil influence future AI regulations in other LATAM countries?
At Pure Global, we offer end-to-end regulatory consulting solutions for Medical Technology and In-Vitro Diagnostic companies. We combine local expertise with advanced AI and data tools to streamline your global market access, including navigating complex new frameworks like Brazil's AI regulations. To get your product to market efficiently and correctly, contact us at [email protected] or visit https://pureglobal.com/.